Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?

Gnant M, Dubsky P, Fitzal F, Blaha P, Schoppmann S, Steger G, Marth C, Samonigg H, HГјttner K, Fohler H, Ruecklinger E, Jakesz R, Greil R Clin Breast Cancer. 2009 Jun,9 Suppl 1:S18-27. doi: 10.3816/CBC.2009.s.002. Review.

Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insights.

Hartmann TN, Pleyer L, Desch P, Egle A, Greil R. Discov Med. 2009 Oct,8(42):157-64.

PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.

Holler C, PiГ±Гіn JD, Denk U, Heyder C, Hofbauer S, Greil R, Egle A. Blood. 2009 Mar 19,113(12):2791-4. doi: 10.1182/blood-2008-06-160713. Epub 2009 Jan 23.

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.

Sonneveld P, Hajek R, Nagler A, Spencer A, BladГ© J, Robak T, Zhuang SH, Harousseau JL, Orlowski RZ Cancer. 2008 Apr 1,112(7):1529-37. doi: 10.1002/cncr.23326.

Erythropoietins in cancer patients: ESMO recommendations for use.

Greil R, Thödtman R, Roila F Ann Oncol. 2008 May,19 Suppl 2:ii113-5. doi: 10.1093/annonc/mdn106.

MULTIPLE MYELOMA – CHEMOKINE NETWORK: CCL27/CTACK – A NEW PLAYER IN MYELOMA PROGRESSION

Olivier, A, Unger, M, Maizner, E, Neureiter, D, Greil, R, Johrer, K ANTICANCER RES. 2008, 28(5C): 3429-3429.

The single nucleotide polymorphism MDM2-SNP309 influences sensitivity of B-CLL cells to the non-genotoxic activator of the p53 pathway Nutlin-3a

Tinhofer, I, Seyfried, I, Stoecher, M, Hofbauer, S, Daniel, PT, Greil, R J CLIN ONCOL. 2008, 26(15):

ZOLEDRONIC ACID (ZOL) IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH EARLY BREAST CANCER (ERBC) RECEIVING ADJUVANT ENDOCRINE THERAPY: MULTIVARIATE ANALYSIS OF EFFICACY DATA FROM THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP (ABCSG)-12

Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Steger, GG, Bjelic-Radisic, V, Jakesz, R, Kubista, E, Marth, C, Greil, R ANN ONCOL. 2008, 19: 44-44.

Twelve-year retrospective analysis of lung cancer-The TYROL Study: Daily routine in 1,424 patients (1995-2006)

Fiegl, M, Hilbe, W, Auberger, J, Schmid, T, Auberger, T, Tzankov, A, Sterlacci, W, Denz, H, Jamnig, H, Greil, R J CLIN ONCOL. 2008, 26(15):

Hematopoietic growth factors: ESMO recommendations for the applications.

Greil R, Psenak O, Roila F Ann Oncol. 2008 May,19 Suppl 2:ii116-8. doi: 10.1093/annonc/mdn107.